Ramakrishnan R Srinivasan
Overview
Explore the profile of Ramakrishnan R Srinivasan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lei J, Dobrolecki L, Huang C, Srinivasan R, Vasaikar S, Lewis A, et al.
bioRxiv
. 2024 Dec;
PMID: 39713418
Combination chemotherapy remains essential for clinical management of triple-negative breast cancer (TNBC). Consequently, responses to multiple single agents cannot be delineated at the single patient level, even though some patients...
2.
Espinoza A, Patel R, Patel K, Badachhape A, Whitlock R, Srivastava R, et al.
J Hepatol
. 2024 Jan;
80(4):610-621.
PMID: 38242326
Background & Aims: Patients with metastatic, treatment-refractory, and relapsed hepatoblastoma (HB) have survival rates of less than 50% due to limited treatment options. To develop new therapeutic strategies for these...
3.
Petrosyan V, Dobrolecki L, Thistlethwaite L, Lewis A, Sallas C, Srinivasan R, et al.
iScience
. 2023 Jan;
26(1):105799.
PMID: 36619972
Although systemic chemotherapy remains the standard of care for TNBC, even combination chemotherapy is often ineffective. The identification of biomarkers for differential chemotherapy response would allow for the selection of...
4.
Chen B, Solis-Villa C, Hakenberg J, Qiao W, Srinivasan R, Yasuda M, et al.
Hum Mutat
. 2016 Aug;
37(11):1215-1222.
PMID: 27539938
Acute intermittent porphyria results from hydroxymethylbilane synthase (HMBS) mutations that markedly decrease HMBS enzymatic activity. This dominant disease is diagnosed when heterozygotes have life-threatening acute attacks, while most heterozygotes remain...